Home Blog Page 1068

AMTD Reached Deals on the Acquisition of a London Office Tower, in Conjunction with Amendment to Terms of Acquisition of the London Hornsey Town Hall Project, with Total Transaction Value at US$87.7 Million

By
Advertorial Desk
-

PARIS and NEW YORK and LONDON, March 10, 2026 /PRNewswire/ — AMTD Group Inc. (“AMTD Group”), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group (“TGE”, NYSE: TGE; LSE: TGE), a subsidiary of AMTD Digital Inc., jointly announce that AMTD IDEA Group  entered into a term sheet (the “Term Sheet”) with FEC Property Holdings (UK) Limited (“the Office Seller”) and FEC Finance Limited (the “Lender”) pursuant to which, among others things, (i) AMTD IDEA Group agrees to acquire from the Office Seller an office building located at 40, Furnival Street, London, EC4A 1JQ (the “Office”) at a consideration of approximately US$24.0 million (the “Office Transaction”); (ii) the Lender agrees to grant a term loan (the “Loan”) of approximately US$51.0 million (subject to adjustment as set out in the terms of the Term Sheet) to AMTD IDEA Group for the sole purpose of settling the consideration for the Office Transaction as well as the previously announced acquisition by AMTD IDEA Group of the London Hornsey Town Hall project comprising a hotel property and adjacent town hall space from Far East Consortium International Limited (0035.HK) (the “Horney Transactions”, and collectively with the Office Transaction, the “Transactions”); and (iii) the terms of the Hornsey Transactions as previously agreed shall be amended to be in line with the terms of the Term Sheet including in respect of the closing date of the Hornsey Transactions.

The aggregate consideration for the Transactions is approximately US$87.7 million (subject to certain net asset value adjustments), including (i) approximately US$24.0 million for the Office Transaction; (ii) approximately US$30.3 million for the hotel component of the Horney Transactions; and (iii) approximately US$32.8 million for the town hall component of the Horney Transactions. The Loan has a term of five years and carries an interest of 5% per annum; interests accrue and are payable on the Loan every 6 months. AMTD IDEA Group agrees to charge, among other things, the Office, the townhall property, the hotel property and all the issued shares of the operating companies of the townhall and the hotel, to the Lender as securities for the repayment of the Loan. The Transactions are expected to be completed simultaneously and in March 2026, subject to the execution of definite agreements and closing conditions set forth therein.

The acquisition underscores the deepening strategic partnership between AMTD and FEC, building on a strong track record of collaboration across landmark hospitality projects such as Dao by Dorsett AMTD Singapore and The Ritz–Carlton Perth in Australia.

The Transactions also highlight AMTD’s diversified, multi–dimensional business strategy and extensive regional footprint. Through the planned acquisition a premium hotel, historic townhall, and an office tower in prime London locations, AMTD is expected to further strengthen its strategic foothold in the European region and complements its broader global portfolio of hospitality and commercial real estate assets.

Dr. Feridun Hamdullahpur, the independent chairman of AMTD IDEA Group commented, “Acquiring these key London assets marks an important milestone in AMTD’s expansion strategy across major international gateways. This transaction deepens our long–term strategic partnership with FEC and underscores AMTD IDEA Group’s ambition to build a leading global portfolio of high–quality hospitality and commercial real estate assets.”

Dr. Timothy Tong, the independent chairman of AMTD Digital commented, “The acquisition of Hornsey Hotel signifies another major milestone in AMTD Digital’s development in the hospitality industry.   AMTD Digital will be well positioned to serve an important metropolitan area that is steeped in history and culture.”

Raymond Yung, the independent director of TGE commented, “TGE is well positioned to capture the continuing growth in the tourism industry around the world. These acquisitions are solid proof of TGE’s financial and operational strength in this strategic segment of our business.”

About AMTD Group

AMTD Group is a conglomerate with a core business portfolio spanning across media and entertainment, education and training, and premium assets and hospitality sectors.

 About AMTD IDEA Group

AMTD IDEA Group (NYSE: AMTD; SGX: HKB) represents a diversified institution and digital solutions group connecting companies and investors with global markets. Its comprehensive one-stop business services plus digital solutions platform addresses different clients’ diverse and inter-connected business needs and digital requirements across all phases of their life cycles. AMTD IDEA Group is uniquely positioned as an active super connector between clients, business partners, investee companies, and investors, connecting the East and the West. For more information, please visit www.amtdinc.com or follow us on X (formerly known as “Twitter”) at @AMTDGroup.

About AMTD Digital Inc.

AMTD Digital Inc. (NYSE: HKD) is a comprehensive digital solutions platform headquartered in France. Its one-stop digital solutions platform operates key business lines including digital media, content and marketing services, investments as well as hospitality and VIP services. For AMTD Digital’s announcements, please visit https://ir.amtdigital.net/investor-news.

About The Generation Essentials Group

The Generation Essentials Group (NYSE: TGE; LSE: TGE), jointly established by AMTD Group, AMTD IDEA Group (NYSE: AMTD; SGX: HKB) and AMTD Digital Inc. (NYSE: HKD), is headquartered in France and focuses on global strategies and developments in multi-media, entertainment, and cultural affairs worldwide as well as hospitality and VIP services. TGE comprises L’Officiel, The Art Newspaper, movie and entertainment projects. Collectively, TGE is a diversified portfolio of media and entertainment businesses, and a global portfolio of premium properties. Also, TGE is a special purpose acquisition company (SPAC) sponsor manager, with its first SPAC successfully raised and priced on December 18, 2025.

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and similar statements. Statements that are not historical facts, including statements about the beliefs, plans, and expectations of AMTD IDEA Group, AMTD Digital and/or The Generation Essentials Group, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding these and other risks is included in the filings of AMTD IDEA Group, AMTD Digital and The Generation Essentials Group with the SEC. All information provided in this press release is as of the date of this press release, and none of AMTD IDEA Group, AMTD Digital and The Generation Essentials Group undertakes any obligation to update any forward-looking statement, except as required under applicable law.

For more information, please contact:

For AMTD IDEA Group:
IR Office
AMTD IDEA Group
EMAIL: ir@amtdinc.com 

For AMTD Digital Inc.:
IR Office
AMTD Digital Inc.
EMAIL: ir@amtdigital.net 

For The Generation Essentials Group:
IR Office
The Generation Essentials Group
EMAIL: ir@tge.media 

Registrational Phase III AMPLIFY trial: Target number of participants achieved

By
Advertorial Desk
-

SYDNEY, March 10, 2026 /PRNewswire/ — Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Phase III AMPLIFY trial (NCT06970847)[1] has now consented  in excess of the planned number of participants following strong demand for study participation at sites in the United States (US) and Australia. Consenting of new patients has stopped at all sites pending completion of remaining screening assessments and confirmation of final enrolment numbers.

AMPLIFY (64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants with Biochemical Recurrence of Prostate Cancer) is a non-randomised, single-arm, open-label, multi-centre, diagnostic clinical trial of 64Cu-SAR-bisPSMA positron emission tomography (PET) in participants with rising or detectable prostate-specific antigen (PSA) after initial definitive treatment at clinical sites across the US and Australia.  

The aim of this registrational study is to investigate the diagnostic ability of 64Cu-SAR-bisPSMA PET/computed tomography (CT) to detect recurrence of prostate cancer in men with PSA levels above 0.2 ng/mL. Evaluation will be across two imaging timepoints: Day 1 (1-4 hours post-administration, same-day imaging) and Day 2 (approximately 24 hours post administration, next-day imaging).

AMPLIFY commenced in May 2025, seeking to enrol approximately 220 participants, and the first trial participant was imaged in the same month at XCancer with Dr Luke Nordquist (Omaha, NE). The data from this study will complement the Phase I/II COBRA[2] and Phase II Co-PSMA[3] trials. Both studies have demonstrated enhanced imaging capabilities of 64Cu-SAR-bisPSMA over standard-of-care (SOC) prostate-specific membrane antigen (PSMA) PET imaging in patients with biochemical recurrence (BCR) of prostate cancer. As a pivotal trial, the final study results from AMPLIFY are intended to provide evidence to support an application to the US Food and Drug Administration (FDA) for approval of 64Cu-SAR-bisPSMA as a new diagnostic imaging agent in BCR of prostate cancer.

64Cu-SAR-bisPSMA is also currently being evaluated in another registrational Phase III trial, CLARIFY (NCT06056830)[4], which is expected to close recruitment in CY2026. Building on the Phase I PROPELLER[5] study, the objective of CLARIFY is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET across same-day and next-day imaging in detecting prostate cancer within the pelvic lymph nodes in patients who are scheduled to undergo radical prostatectomy and pelvic lymph node dissection. The CLARIFY results are intended to support an FDA approval application for 64Cu-SAR-bisPSMA in prostate cancer patients who are candidates for definitive therapy.

Dr Alan Taylor, Executive Chairperson of Clarity Pharmaceuticals, commented, “We are about to enter the realm of a select few Australian companies who have developed a drug at the benchtop of Australian science and completed an international Phase III clinical trial with that drug, taking us one step closer to commercialisation. Our team is excited to have reached this initial recruitment milestone in the AMPLIFY trial in just 9 months since we imaged our first participant in the study. This is no small feat, given we achieved this phenomenal pace of recruitment despite three SOC products already in the market, commercialised by four different companies.

“True to our commitment to the highest standards of clinical research, we recruited participants at numerous different sites across the US and Australia to ensure the trial reflected the broad patient population, real-world clinical settings and various PET cameras in which this product is intended to be used. This strategy required careful planning to allow for all participating sites to contribute to the recruitment, based on allocation of participant numbers to be enrolled per site, resulting in what we believe will be a robust and well-balanced dataset and supporting the integrity and quality of the AMPLIFY study.

“Despite the variations in the sites’ activation times, the speed of enrolment in this trial not only highlights the unmet need in the BCR space but also indicates the strong demand for 64Cu-SAR-bisPSMA from clinicians and patients seeking more effective and accurate prostate cancer detection diagnostics. With persistent outreach from participating sites to enrol more patients, clinicians and patients would rather use an unapproved product, undertaking additional demands of a clinical trial, than rely on the findings of the current SOC PSMA PET.

“To date, we have imaged approximately 600 patients with prostate cancer with 64Cu-SAR-bisPSMA, and just in the last year we scanned over 350 of them. The growing demand for better imaging is driven by so many men around the world with prostate cancer who seek accurate and timely identification of disease location and recurrence. We are committed to answering these needs of patients, clinicians and imaging facilities with a next-generation diagnostic imaging agent specifically designed to deliver significant benefits in efficacy, clinical management, quality of life and operational flexibility across the prostate cancer care pathway.

“The results on 64Cu-SAR-bisPSMA generated to date, from our initial discovery and pre-clinical work, to the recently announced Co-PSMA and the COBRA trials, constitute an extensive body of evidence against SOC, demonstrating that maximal clinical benefit of PSMA PET can be derived through the combination of the proprietary SAR-bisPSMA agent and optimised imaging timepoints facilitated by the half-life of copper-64. Achieving a two to three times improvement in lesion detection over SOC in BCR is an incredible achievement. We believe we can grow the blockbuster PSMA PET market even further with a product that has shown impressive efficacy in clinical trials coupled with many logistical and supply chain benefits. Our team will be working closely with our vendors and participating sites to advance the final data package and with regulatory authorities to get this product to patients in need as soon as possible.

“We also look forward to closing recruitment in the CLARIFY trial this year and progressing our theranostic Phase I/IIa SECuRE trial towards completion. Together with three Fast Track Designations we have for SAR-bisPSMA and positive interactions with the US FDA to date, these milestones place us closer than ever to commercialisation of this exciting agent through the entirety of the prostate cancer journey, from first detection to late-stage metastatic disease.”

About SAR-bisPSMA

SAR-bisPSMA derives its name from the word “bis”, which reflects a novel approach of connecting two PSMA-targeting agents to Clarity’s proprietary sarcophagine (SAR) technology that securely holds copper isotopes inside a cage-like structure, called a chelator. Unlike other commercially available chelators, the SAR technology prevents copper leakage into the body. SAR-bisPSMA is a Targeted Copper Theranostic (TCT) that can be used with isotopes of copper-64 (Cu-64 or 64Cu) for imaging and copper-67 (Cu-67 or 67Cu) for therapy.

Disclaimer

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA are unregistered products. Their safety and efficacy have not been assessed by health authorities such as the US FDA or the Therapeutic Goods Administration (TGA). There is no guarantee that these products will become commercially available.

About Prostate Cancer

Prostate cancer is the second most common cancer diagnosed in men globally and the fifth leading cause of cancer death in men worldwide[6]. Prostate cancer is the second-leading cause of cancer death in American men. The American Cancer Institute estimates there will be about 333,830 new cases of prostate cancer in the US in 2026 and around 36,320 deaths from the disease[7].

For more information, please contact:

Clarity Pharmaceuticals

Dr Alan Taylor 

Lisa Sadetskaya

Executive Chairperson

Director, Corporate Communications

ataylor@claritypharm.com   

lisa@claritypharm.com 

References

  1. ClinicalTrials.gov Identifier: NCT06970847. https://clinicaltrials.gov/study/NCT06970847 
  2. Nordquist et al. COBRA: Assessment of safety and efficacy of 64Cu-SAR-bisPSMA in patients with biochemical recurrence of prostate cancer following definitive therapy. EANM, 2024.
  3. Clarity Pharmaceuticals. Co-PSMA: Cu-64 SAR-bisPSMA more than doubled prostate cancer lesion and patient detection vs. Ga-68 PSMA-11 in head-to-head trial. https://www.claritypharmaceuticals.com/news/abstract-eau-2026/
  4. ClinicalTrials.gov Identifier: NCT06970847. https://clinicaltrials.gov/study/NCT06907641
  5. Veronica Wong, Nat Lenzo, Michelle Parker and Louise Emmett. 64Cu-SAR-bisPSMA (PROPELLER) positron emission tomography (PET) imaging in patients with confirmed prostate cancer. JCO 41, 5039-5039(2023). DOI:10.1200/JCO.2023.41.16_suppl.5039
  6. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21660
  7. American Cancer Society: Key Statistics for Prostate Cancer. https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html

This announcement has been authorised for release by the Executive Chairperson.

Big Tree Cloud Holdings Limited Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

By
Advertorial Desk
-

SHENZHEN, China, March 10, 2026 /PRNewswire/ — Big Tree Cloud Holdings Limited (the “Company”) (NASDAQ: DSY) today announced that it has received a written compliance notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) dated March 9, 2026, informing the Company that it has regained compliance with the minimum bid requirement price of US$1.00 per share under Nasdaq Listing Rule 5450(a)(1).

As previously announced, on November 18, 2025, the Company was notified by Nasdaq that it was not in compliance with the Minimum Bid Price Requirement, as the closing bid price of the Company’s ordinary shares (“Ordinary Shares”) was below US$1.00 per share for 30 consecutive business days. The Company was provided with a compliance period of 180 calendar days, or until May 18, 2026, to regain compliance under the Minimum Bid Price Requirement.

Nasdaq has determined that the closing bid price of the Company’s Ordinary Shares has been at or above US$1.00 per share for the last 10 consecutive business days, from February 23, 2026 to March 6, 2026. Accordingly, Nasdaq has confirmed that the Company has regained compliance with the Minimum Bid Price Requirement.

The Company will continue to focus on strengthening its core business operations and advancing its strategic initiatives, including the exploration of opportunities in emerging sectors such as artificial intelligence. The Company remains committed to maintaining compliance with all applicable Nasdaq listing standards while pursuing sustainable long-term growth.

About Big Tree Cloud

Founded in 2020, Big Tree Cloud is positioned as an international capital platform focused on industrial integration and strategic investment in China’s personal care industry. The Company is committed to empowering industries through capital operations. Currently, Big Tree Cloud is accelerating its expansion into the AI sector. This new business line aims to capture the growing market demand for AI skills, injecting fresh momentum into the Company’s development.

Forward-Looking Statements

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Statements that are not historical facts, including but not limited to statements about Big Tree Cloud Holdings Limited’s (the “Company”) beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s ability to achieve its goals and strategies; its future business development, financial condition and results of operations; the growth of, and trends in, the markets in which the Company operates; its ability to successfully expand into the AI sector and capture market demand; its ability to maintain and enhance its brand and reputation; its reliance on its relationship with its customers and end-users; changes in laws and regulations affecting its business; general economic and business conditions globally and in China; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company’s filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and the Company undertakes no duty to update such information, except as required under applicable law.

Investor Relations Contact
Ting Yan
Phone: +86 15986815865
Email: yanting@bigtreeclouds.com

HR Path Strengthens Advisory Expertise in North America with the Acquisition of Inspire HR

By
Advertorial Desk
-

PARIS, March 10, 2026 /PRNewswire/ — HR Path, a global leader in HR consulting and HRIS solutions, is proud to announce the strategic acquisition of Inspire Human Resources (Inspire HR), a U.S.-based HR advisory firm recognized for its deep expertise in addressing complex HR challenges and critical talent needs.

With a presence in 28 countries and a team of over 2,500 professionals, HR Path is a trusted partner for businesses navigating the complexities of Human Resources. Specializing in advisory, implementation, and operational services, HR Path delivers cutting-edge solutions designed to enhance efficiency and foster growth. Since its founding in 2001, the company has remained steadfast in its mission to transform HR practices globally.

Founded in 2007 by Jaime Klein, Inspire HR trailblazed the fractional HR model, building a strong reputation for delivering flexible, senior-level expertise that empowers organizations—from Fortune 500 companies to startups and nonprofits—to bridge talent gaps and accelerate strategic growth. With a team of seasoned experts spanning every major HR discipline, Inspire HR combines hands-on operational support with high-level advisory services. By offering interim, project-based, and advisory solutions, the firm enables businesses to achieve their goals without the overhead of full-time HR staff.

This acquisition marks an important milestone in HR Path’s growth in North America and significantly strengthens the Advisory pillar of its service offering. Inspire HR’s people–centric expertise complements HR Path’s strategic vision to guide organizations not only through HR technology decisions but also through broader people, culture, and organizational transformations.

“The acquisition of Inspire HR marks an important milestone in strengthening our Advisory capabilities in North America, a region that is central to our global growth strategy,” said François Boulet, CEO and Co-Founder at HR Path. “Inspire HR’s exceptional team brings deep expertise across all HR functions, enabling us to better support organizations as they evolve their culture, talent strategies, and people experience. This partnership significantly enhances our presence in the U.S. and reinforces our ambition to be the global reference in HR transformation.”

“In an era of rapid change, organizations need flexible HR talent more than ever,” said Jaime Klein, Founder and CEO of Inspire HR. “We’re excited to join HR Path to serve more organizations as their trusted advisor and go-to fractional HR partner.” 

PDF – https://mma.prnewswire.com/media/2927281/HR_Path_Inspire_HR.pdf 

CONTACT: Fabienne LATOUR – Fabienne.latour@hr-path.com 

Actian Unveils Conversational Analytics Solution with Intelligently Generated Semantic Foundation for Trusted Insights

By
Advertorial Desk
-

Designed to provide enterprise-grade accuracy, Actian AI Analyst uses a Semantic Knowledge Graph to provide business context needed to address AI hallucinations

ROUND ROCK, Texas, March 10, 2026 /PRNewswire/ — Actian, the data and AI division of HCLSoftware, today introduced the Actian AI Analyst (formerly Wobby), a conversational analytics solution featuring the Steward Agent that intelligently generates and provides ongoing maintenance of the semantic layer to speed time to value and deliver trusted, auditable insights. By combining AI-driven analysis with deterministic semantics, Actian AI Analyst allows organizations to scale analytics access, reduce business intelligence bottlenecks, and act on insights with confidence.

Basic AI models generally claim high accuracy in simple tests, but applying them to complex enterprise data often triggers hallucinations and incorrect logic. In fact, Stanford HAI’s 2025 AI Index Report shows that some models’ performance can achieve 97.8% accuracy on simpler planning tasks, but accuracy plummets when reasoning complexity increases and can reach near zero for some models.1 These errors are typically not auditable, creating a significant trust gap.

“Increasingly, enterprises are embedding AI into analytics workflows to accelerate insight generation and decision-making, but speed without trust is a liability,” said Guillaume Bodet, chief product officer at Actian. “Unlike error-prone text-to-SQL tools, the Actian AI Analyst is anchored in governed enterprise data and engineered for full traceability, allowing organizations to scale analytics access for business users without sacrificing accuracy or trust.”

The Steward Agent: Intelligently Build the Data Foundation

The new Steward Agent accelerates AI deployment and replaces time-consuming manual work by intelligently building and maintaining a governed data foundation from existing warehouse schemas and business documentation.

  • Semantic Modeling: Transforms existing business glossaries and documentation into a Semantic Knowledge Graph, enabling organizations to move from raw data to query-ready insights within days or weeks.
  • Consistent Business Logic: Defines and maintains shared business logic to help maintain consistency across departments and prevent metric drift.
  • Proactive Logic Maintenance: Identifies and updates changes in business definitions, allowing the semantic layer to evolve without requiring manual reconfiguration.

The Actian AI Analyst: Accuracy at Scale

The Actian AI Analyst delivers trusted, conversational analytics that allow business users to explore data and uncover insights using natural language. By framing every question within a governed semantic foundation, the solution enables teams to act on verified information in real time.

  • Conversational Interface: Replaces static dashboards with a natural-language interface, allowing business users to ask follow-up questions and receive instant analysis without writing SQL.
  • Constrained Execution Engine: Uses a rules-based approach to ground every answer in the company’s specific logic and eliminates the unconstrained SQL generation that causes AI hallucinations.
  • Full Traceability: Provides visibility into the reasoning steps, filters, and calculations used to produce every answer, allowing users to validate results and resolve discrepancies quickly.

Seamless Integration and Action

Actian AI Analyst integrates directly into existing business workflows to shorten the distance between a question and a strategic decision.

  • Slack and Microsoft Teams Integration: Delivers conversational analytics directly within existing collaboration tools, allowing users to query and receive data then share results without switching applications.
  • Threaded Conversational Context: Maintains the history of a conversation across follow-up questions, enabling insights to evolve naturally without restarting the analysis.
  • Streamlined Operations: Empowers business users to self-serve accurate answers, reducing the operational burden on data teams.

“The Actian AI Analyst turned our BI into a conversation instead of a development cycle,” said Pieter Seyns, Head of Artificial Intelligence at Bekaert, a leader in material science of steel wire transformation and coating technologies. “Faster insights, fewer dashboards—the Actian AI Analyst simply works.”

For organizations looking to extend these capabilities enterprise-wide, Actian AI Analyst can be paired with the Actian Data Intelligence Platform to create a closed-loop system where governed data definitions flow directly into live, conversational analytics.

Availability

The Actian AI Analyst and Steward Agent are available now. The agents will be integrated across the Actian portfolio in the coming quarters. To learn more, read the blog and visit the Actian AI Analyst webpage.

About Actian
Actian empowers enterprises to confidently manage and govern data at scale. Actian data management and data intelligence solutions help streamline complex data environments and accelerate the delivery of AI-ready data. Designed to be flexible, Actian solutions integrate seamlessly and perform reliably across on-premises, cloud, and hybrid environments. Learn more about Actian, the data and AI division of HCLSoftware, at actian.com.

1 Stanford University Human-Centered Artificial Intelligence (HAI), “Artificial Intelligence Index Report 2025,” April 2025.

Media Contact:
Jennifer Harbour
PR Consultant
Jennifer.Harbour@actian.com 

Danielle Lee
Vice President – Global Analyst Relations & Public Relations
Danielle.Lee@actian.com

NYSE Content Update: AT&T CEO John Stankey to Ring Bell on 150th Anniversary of First Phone Call

By
Advertorial Desk
-

NYSE issues a pre-market daily advisory direct from the trading floor.

NEW YORK, March 10, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

AT&T commits $250 billion over five years to network infrastructure.

Kristen Scholer delivers the pre-market update on March 10th

  • The stock market is recovering Tuesday morning, and the price of ICE Brent Crude is cooling after President Donald Trump said that Iran War could “very soon” end.
  • Paris Hilton, alongside activist Gloria Steinem, celebrated International Women’s Day at the NYSE on Monday, March 9, by ringing the Closing Bell.
  • Telecom giant AT&T (NYSE: T) announces a $250 billion commitment to advance U.S. connectivity as it marks the 150th anniversary of the first telephone call.
  • Nexthop AI raises $500 million in funding with an oversubscribed series B round led by Lightspeed Venture partners to boost its valuation to $4.2 billion

Opening Bell
AT&T (NYSE: T) celebrates the 150th anniversary of the first telephone call

Closing Bell
Bunge (NYSE: BG) celebrates its 2026 Investor Day and 25 years as a public company

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

Activists Paris Hilton and Gloria Steinem sign Distinguished Guest Book.
Activists Paris Hilton and Gloria Steinem sign Distinguished Guest Book.

 

Video – https://mma.prnasia.com/media2/2930419/NYSE_Market_Update_March_10.mp4

 

Singapore University of Social Sciences Expands Regional Footprint in China with Launch of Success Academy in Chongqing

By
Advertorial Desk
-

New Academy and Shenyang satellite office strengthen SUSS’ visibility and partnerships across Western and Northeast China.


CHONGQING, CHINA – Media OutReach Newswire – 10 March 2026 – The Singapore University of Social Sciences (SUSS) today launched the SUSS Success Academy in Chongqing in collaboration with Raffles Young Academy (RYA) Pte Ltd and announced the establishment of a satellite office in Shenyang. Building on its Success Academies in Beijing and Shenzhen, the Academy strengthens SUSS’ presence in China and supports its growing engagement across Western and Northeast China.

Guests and partners at the launch event of the Success Academy in Chongqing. (From L-R: Dr Yap Meen Sheng, Assistant Provost, SUSS; Mr Lennon Tan, President, Singapore Manufacturing Federation; Mr Li Xunfu, Deputy Director of Chongqing Municipal Commission of Commerce; Prof Tan Tai Yong, President, SUSS; Mr Samuel Ng, Executive Chairman, Raffles Young Academy; Associate Professor Justina Tan, Vice President, Strategic & Partnership Engagement)
Guests and partners at the launch event of the Success Academy in Chongqing. (From L-R: Dr Yap Meen Sheng, Assistant Provost, SUSS; Mr Lennon Tan, President, Singapore Manufacturing Federation; Mr Li Xunfu, Deputy Director of Chongqing Municipal Commission of Commerce; Prof Tan Tai Yong, President, SUSS; Mr Samuel Ng, Executive Chairman, Raffles Young Academy; Associate Professor Justina Tan, Vice President, Strategic & Partnership Engagement)

The launch was commemorated with an opening ceremony at the CCI Gallery, attended by close to 70 guests from China and Singapore, including representatives from institutions of higher learning, and industry and community partners. The ceremony was presided by Vice-Consul (Political) Ms. Mavis Tan, Consulate-General of the Republic of Singapore, Chengdu and Mr. Li Xunfu, Deputy Director of Chongqing Municipal Commission of Commerce.

Success Academy to connect partners from Singapore and China

Anchored in SUSS’ commitment to lifelong learning and creating social impact, the Academy will serve as a key nexus for academic and industry partners from both countries. Through cross-cultural collaboration and practice-oriented learning, it also aims to develop future-ready talent equipped to contribute meaningfully to society and the economy.

RYA is an education and talent development organisation aimed at nurturing future-ready talent through industry-oriented learning and international exposure. RYA will bring its networks and local expertise to support and enhance the Academy’s initiatives.

Through the Academy, SUSS will provide opportunities for students from SUSS and other Singapore pre-tertiary and tertiary institutions to co-learn and co-innovate with peers in China. These include interdisciplinary global learning courses, impact startup and venture builder programmes, industry-based immersions and student exchanges. SUSS students will also gain regional exposure through internships and other workplace learning opportunities. In addition, the Academy will support SUSS in working with universities and organisations in China to jointly design and deliver industry-relevant courses and programmes for students and executives.

Extending engagement into Northeast China with Shenyang satellite office

To further deepen its engagement in Northeast China, SUSS will launch a satellite office in Shenyang on 11 March 2026 under the Success Academy in Chongqing. This office will support SUSS’ initiatives in Liaoning Province and surrounding areas, including Dalian. In addition, three Memoranda of Understanding (MOU) will be signed with the following organisations:

  • Shenyang University of Chemical Technology (SYUCT): Collaborative development of a Master’s degree programme in Social Work, fostering cross-border knowledge exchange, curriculum innovation, and talent development to address evolving social service needs.
  • North-East Institute of Population and Social Development: Joint research endeavours, professional development programmes, and meaningful academia-industry partnerships to generate evidence-based solutions, build capabilities, and promote active ageing ecosystems that benefit individuals and communities.

Professor Tan Tai Yong, President of SUSS, said, “China is an important partner for SUSS as we expand opportunities for our students and strengthen collaboration across Asia. The launch of the Success Academy in Chongqing allows us to work more closely with universities, industry and community partners in Western and Northeast China, and to deliver applied, practice-oriented education that responds to real-world needs. Our partnership with Raffles Young Academy reflects our shared commitment to developing future-ready talent and supporting professional growth across the region.”

Mr. Samuel Ng, Executive Chairman, RYA, said, “Our collaboration with the Singapore University of Social Sciences reflects a shared belief in applied, practice-oriented education and in preparing students and enterprises to navigate an increasingly complex and interconnected world. Chongqing’s strategic position as a gateway to Western China and a hub for industry and connectivity makes it an ideal location for immersive, industry-linked education. This partnership represents a long-term commitment to building enduring bridges between students and industry, between academia and practice, and between Singapore and China.”

The launch of the Success Academy in Chongqing is part of SUSS’ broader expansion across Asia. Since 2023, SUSS has established Success Academies in Beijing, Shenzhen, Ho Chi Minh City Bangkok, Kuala Lumpur, Jakarta, Manila and Mumbai.

For more information, visit www.suss.edu.sg/success-academy.
Hashtag: #SUSS




The issuer is solely responsible for the content of this announcement.

GAC Ranks Second Among Chinese Brands and Third Overall in Hong Kong EV Sales!

By
Advertorial Desk
-

HONG KONG, March 10, 2026 /PRNewswire/ — Since early this year, GAC’s overseas markets have shown strong coordinated growth. The Asia-Pacific region registered a 130% year-on-year sales growth in January-February, with substantial increases in Singapore, Indonesia, the Philippines and other markets. In January, newly registered brand vehicles in Thailand surged 438% year-on-year and 234% month-on-month.

Among them, AION delivered a remarkable performance in Hong Kong. According to the latest registration data for new electric private cars released by the Hong Kong Transport Department in February 2026, AION has surged to become the third best-selling EV brand overall in Hong Kong and ranks second among Chinese brands, demonstrating strong growth momentum and deep market recognition.

This achievement marks the successful implementation of market strategy. Since launching the “Hong Kong ACTION” strategy in 2025, AION has established a comprehensive presence across products, channels, services, energy systems, and mobility ecosystems, deeply cultivating and serving the Hong Kong market.

After breaking into the market’s TOP 3 multiple times in 2025, the brand has once again validated the competitiveness and reputation of “Intelligent Manufacturing in China” with solid sales data at the beginning of 2026.

As a top-two Chinese brand in EV sales, AION has won the trust of Hong Kong consumers through precise product positioning and excellent quality. Currently, its four main models—AION V, AION UT, AION ES, and HYPTEC HT—are meeting diverse user needs with their unique advantages.

This honor received by AION in Hong Kong is a significant outcome of the “Hong Kong ACTION” strategy’s implementation. Guided by the “One GAC 2.0” globalization strategy, Hong Kong, serving as the “bridgehead” for GAC’s global strategy, is being accelerated into another benchmark overseas market. This represents not only quantitative growth but also a “qualitative leap” achieved by pursuing a path of high-quality international expansion with GAC characteristics.

Looking ahead, GAC will uphold its brand values of “quality leadership, technological innovation” and its brand philosophy of “service first, customer foremost.” Taking Hong Kong as a model, we will adhere to the principle of “In Local For Local,” striving to become a creator of low-carbon, green and intelligent mobility value for a better life.

For further information about GAC, please visit: https://www.gacgroup.com/en or follow us on social.


 

1...1,0671,0681,069...6,708Page 1,068 of 6,708